🇺🇸 FDA
Patent

US 10302602

Process of conducting high throughput testing high performance liquid chromatography

granted A61PA61P11/00

Quick answer

US patent 10302602 (Process of conducting high throughput testing high performance liquid chromatography) held by Vertex Pharmaceuticals Incorporated expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P11/00